EB-OCT Biopsy Guidance of Lung Cancer

NANot yet recruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

September 30, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

January 31, 2027

Conditions
Lung Cancer
Interventions
DEVICE

Optical coherence tomography

In the OCT-guided biopsy arm, n=100 study subjects will be enrolled. The investigators will conduct biopsies and imaging using our newly developed OCT catheters and real-time image processing and display algorithms.

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Massachusetts General Hospital

OTHER

NCT06556680 - EB-OCT Biopsy Guidance of Lung Cancer | Biotech Hunter | Biotech Hunter